Filing Details
- Accession Number:
- 0000950170-25-095681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-14 21:27:12
- Reporting Period:
- 2025-07-10
- Filing Date:
- 2025-07-14
- Accepted Time:
- 2025-07-14 21:27:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1327273 | Lyra Therapeutics Inc. | LYRA | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1883290 | Jason Cavalier | C/O Lyra Therapeutics, Inc. 480 Arsenal Way Watertown MA 02472 | Chief Financial Officer | No | No | No | No |
Transaction Summary
Sold: | 684 shares | Avg. Price: $8.91 | Total Value: $6,094.44 |
Number of Shares After Transactions: | 519,316 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-10 | 684 | $8.91 | 519,316 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold to cover taxes upon the vesting of restricted stock units ("RSUs") pursuant to a mandatory Rule 10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.